Indian Journal of Medical Microbiology最新文献

筛选
英文 中文
Outbreak of Burkholderia cenocepacia in an intensive care unit of a tertiary care hospital identified by pulsed-field gel electrophoresis 通过脉冲场凝胶电泳鉴定一家三甲医院重症监护室爆发的伯克霍尔德氏伤寒杆菌。
IF 1.4 4区 医学
Indian Journal of Medical Microbiology Pub Date : 2024-07-01 DOI: 10.1016/j.ijmmb.2024.100655
Mahalakshmi Kumaresan, Meerabai Manoharan, Madhan Sugumar, Sujatha Sistla
{"title":"Outbreak of Burkholderia cenocepacia in an intensive care unit of a tertiary care hospital identified by pulsed-field gel electrophoresis","authors":"Mahalakshmi Kumaresan,&nbsp;Meerabai Manoharan,&nbsp;Madhan Sugumar,&nbsp;Sujatha Sistla","doi":"10.1016/j.ijmmb.2024.100655","DOIUrl":"10.1016/j.ijmmb.2024.100655","url":null,"abstract":"<div><p>Nosocomial outbreaks of <em>Burkholderia cepacia</em> complex, transmitted through contaminated medical surfaces or equipment have been reported. Pulsed-field Gel Electrophoresis (PFGE) is recognized as the “gold standard” for molecular subtyping, yet studies on clonal relationships in India are limited. PFGE was used to study the clonal relationships of 22 isolates of <em>Burkholderia cenocepacia</em> from 12 patients admitted to a critical care unit during 2 months (November and December 2021). PFGE revealed three different profiles with 15 isolates belonging to a single cluster suggesting a common source within the hospital, emphasizing the need for preventive measures to control <em>B. cenocepacia</em> transmission.</p></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"50 ","pages":"Article 100655"},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141446027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aquatic whispers: Decoding skin manifestation of Aeromonas hydrophila 水生私语:解码嗜水气单胞菌的皮肤表现。
IF 1.4 4区 医学
Indian Journal of Medical Microbiology Pub Date : 2024-07-01 DOI: 10.1016/j.ijmmb.2024.100658
Nilakshi Gupta, Vikas Manchanda, Rohit Sinha, Sonal Saxena
{"title":"Aquatic whispers: Decoding skin manifestation of Aeromonas hydrophila","authors":"Nilakshi Gupta,&nbsp;Vikas Manchanda,&nbsp;Rohit Sinha,&nbsp;Sonal Saxena","doi":"10.1016/j.ijmmb.2024.100658","DOIUrl":"10.1016/j.ijmmb.2024.100658","url":null,"abstract":"<div><p>The <em>Aeromonadaceae</em> family, comprised of gram-negative bacilli, is ubiquitously distributed across the globe. Infections by Aeromonas species encompass gastroenteritis, septicaemia, skin and soft tissue infections (SSTIs), pneumonia, and peritonitis. This report delineates a case of <em>Aeromonas hydrophila</em> infection, manifesting as an array of pustules on the patient's lower extremities subsequent to the ingestion of marine crustaceans, specifically prawns. Prompt diagnosis and the initiation of an appropriate antibiotic regimen are imperative to mitigate the risk of further complications.</p></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"50 ","pages":"Article 100658"},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141456451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis of mucormycosis from nasal swabs using commercial PCR platforms; a feasible alternative? 利用商用 PCR 平台从鼻拭子诊断粘孢子菌病;可行的替代方案?
IF 1.4 4区 医学
Indian Journal of Medical Microbiology Pub Date : 2024-07-01 DOI: 10.1016/j.ijmmb.2024.100661
Gagandeep Singh , Piyush Ranjan , Souradeep Chowdhury , Sunit Sikdar , Tamoghna Ghosh , Janya Sachdev , Renu Kumari Yadav , Aakashneel Bhattacharya , Mragnayani Pandey , Immaculata Xess , Ms Sonakshi Gupta , Naveet Wig
{"title":"Diagnosis of mucormycosis from nasal swabs using commercial PCR platforms; a feasible alternative?","authors":"Gagandeep Singh ,&nbsp;Piyush Ranjan ,&nbsp;Souradeep Chowdhury ,&nbsp;Sunit Sikdar ,&nbsp;Tamoghna Ghosh ,&nbsp;Janya Sachdev ,&nbsp;Renu Kumari Yadav ,&nbsp;Aakashneel Bhattacharya ,&nbsp;Mragnayani Pandey ,&nbsp;Immaculata Xess ,&nbsp;Ms Sonakshi Gupta ,&nbsp;Naveet Wig","doi":"10.1016/j.ijmmb.2024.100661","DOIUrl":"10.1016/j.ijmmb.2024.100661","url":null,"abstract":"<div><p>Rhino-orbital-cerebral mucormycosis (ROCM) is linked to uncontrolled diabetes, diabetic ketoacidosis, iron overload, corticosteroid therapy, and neutropenia. This study evaluated a commercial real-time PCR system's effectiveness in detecting Mucorales from nasal swabs in 50 high-risk patients. Nasal swab PCR showed 30% positivity, compared to 8% with KOH microscopy. Despite its improved sensitivity, nasal swab PCR has limitations, highlighting the importance of established sampling methods in mucormycosis diagnosis. Participants were predominantly male (64%), with diabetes (78%) and amphotericin B use (96%). Prior COVID-19 was 42%, with 30% positive for Mucorales by PCR, compared to 8% with KOH microscopy.</p></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"50 ","pages":"Article 100661"},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141476519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antimicrobial resistance pattern of Helicobacter pylori in patients evaluated for dyspeptic symptoms in North-Eastern India with focus on detection of clarithromycin resistance conferring point mutations A2143G and A2142G within bacterial 23S rRNA gene 在印度东北部接受消化不良症状评估的患者中发现幽门螺旋杆菌的抗菌药耐药性模式,重点检测细菌 23S rRNA 基因中的 A2143G 和 A2142G 点突变赋予克拉霉素耐药性。
IF 1.4 4区 医学
Indian Journal of Medical Microbiology Pub Date : 2024-07-01 DOI: 10.1016/j.ijmmb.2024.100652
Saranya Datta , Annie B. Khyriem , Kyrshanlang G. Lynrah , Evarisalin Marbaniang , Noor Topno
{"title":"Antimicrobial resistance pattern of Helicobacter pylori in patients evaluated for dyspeptic symptoms in North-Eastern India with focus on detection of clarithromycin resistance conferring point mutations A2143G and A2142G within bacterial 23S rRNA gene","authors":"Saranya Datta ,&nbsp;Annie B. Khyriem ,&nbsp;Kyrshanlang G. Lynrah ,&nbsp;Evarisalin Marbaniang ,&nbsp;Noor Topno","doi":"10.1016/j.ijmmb.2024.100652","DOIUrl":"10.1016/j.ijmmb.2024.100652","url":null,"abstract":"<div><h3>Purpose</h3><p>In India there is evidence of antimicrobial resistance in <em>Helicobacter pylori</em>, a definitive pathobiont whose only known niche is human gastric mucosa. This in turn can lead to failure of treatment, persistence or chronicity of infection. This hospital based, prospective, observational study investigates the presence of antimicrobial resistance in the organism with focus on detection of A2143G and A2142G major point mutations in domain V of <em>H. pylori</em> 23S rRNA gene as a molecular mechanism of conferring resistance.</p></div><div><h3>Methods</h3><p>Endoscopic gastric biopsy samples from 52 patients presenting with dyspeptic symptoms from January 2016 to December 2016 were subjected to culture in a microaerophilic environment using Campylobacter agar with for 2–5 days. Isolates were identified using gram-staining, motility test and biochemical reactions. Modified Kirby-Bauer Disc diffusion method was used to determine antimicrobial susceptibility against Clarithromycin, Metronidazole, Amoxycillin, Levofloxacin, Tetracycline, Cotrimoxazole and Erythromycin. Additionally, detection of A2143G and A2142G point mutations conferring Clarithromycin resistance was carried out using real time PCR following extraction and quantification of bacterial DNA. Histopathological examination was carried out on all biopsy samples. Descriptive and inferential statistical analytical methods were used. Differences were considered significant for p &lt; 0.05.</p></div><div><h3>Results</h3><p>Culture positivity for <em>H. pylori</em> by phenotypic method was found to be 36.54%. Histopathologic Examination detected <em>H. pylori</em> in 55.7% and PCR detected 48.08% for either the wild type or one of two mutant strains A2143G and A2142G. No sample was found positive for both mutations. Metronidazole showed the highest resistance among antibiotics (78.9%) followed by Clarithromycin (47.3%).</p></div><div><h3>Conclusion</h3><p>Prevalence of antimicrobial resistance in <em>H. pylori</em> in North-Eastern India is substantially high with A2143G mutation being clinically most important in conferring Clarithromycin resistance. This resistance might be associated with low eradication rates despite initiation of therapy. ROC analysis of PCR proved it to be a good diagnostic tool.</p></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"50 ","pages":"Article 100652"},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141436814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An interesting report of COVID-19 associated mucormycosis (CAM) cases by two different species of Mucorales 一份有趣的报告称,两种不同种类的粘菌感染了与 COVID-19 相关的粘孢子虫病(CAM)病例。
IF 1.4 4区 医学
Indian Journal of Medical Microbiology Pub Date : 2024-07-01 DOI: 10.1016/j.ijmmb.2024.100656
Harsimran Kaur , Rimjhim Kanaujia , Gyanaranjan Nayak , Anurag Snehi Ramavat , Sourabha Patro , Anup Ghosh , Arunaloke Chakrabarti , Shivaprakash M. Rudramurthy
{"title":"An interesting report of COVID-19 associated mucormycosis (CAM) cases by two different species of Mucorales","authors":"Harsimran Kaur ,&nbsp;Rimjhim Kanaujia ,&nbsp;Gyanaranjan Nayak ,&nbsp;Anurag Snehi Ramavat ,&nbsp;Sourabha Patro ,&nbsp;Anup Ghosh ,&nbsp;Arunaloke Chakrabarti ,&nbsp;Shivaprakash M. Rudramurthy","doi":"10.1016/j.ijmmb.2024.100656","DOIUrl":"10.1016/j.ijmmb.2024.100656","url":null,"abstract":"<div><p>During surge of COVID-19-associated mucormycosis (CAM), we identified five cases of CAM where two different species of Mucorales were isolated. All had history of diabetes mellitus and presented with clinical features suggesting rhino-orbital mucormycosis. The patients grew different species from their nasal scraping/biopsy samples, <em>Rhizopus arrhizus</em>, <em>R. homothallicus</em> (n = 2); <em>R. homothallicus</em>, <em>Lictheimia corymbifera</em> (n = 1); <em>R. arrhizus, Mucor</em> spp (n = 1); and <em>L. corymbifera, Apophysomyces variabilis</em> (n = 1). All patients underwent surgical and medical (liposomal amphotericin B) treatment. All, except one growing <em>A. variabilis</em> and <em>L. corymbifera</em> survived. Mixed infection by more than one Mucorales in CAM is unique and warrants epidemiological investigation.</p></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"50 ","pages":"Article 100656"},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141456450","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative study of antifungal susceptibility testing methods for clinical Candida albicans isolates 临床白色念珠菌分离物抗真菌药敏试验方法比较研究
IF 1.4 4区 医学
Indian Journal of Medical Microbiology Pub Date : 2024-07-01 DOI: 10.1016/j.ijmmb.2024.100663
Xue Ting Tan, Nurliyana binti Mohd Shuhairi, Ratna Mohd Tap, Fairuz Amran
{"title":"Comparative study of antifungal susceptibility testing methods for clinical Candida albicans isolates","authors":"Xue Ting Tan,&nbsp;Nurliyana binti Mohd Shuhairi,&nbsp;Ratna Mohd Tap,&nbsp;Fairuz Amran","doi":"10.1016/j.ijmmb.2024.100663","DOIUrl":"10.1016/j.ijmmb.2024.100663","url":null,"abstract":"<div><h3>Purpose</h3><p><em>Candida albicans</em> is the second most common cause of candidemia in Malaysia. The Clinical and Laboratory Standards Institute (CLSI) broth microdilution method is the gold standard for determining its minimum inhibitory concentration (MIC); however, it is laborious and time-consuming. This study was conducted to evaluate the usefulness of alternative methods, namely Sensititre YeastOne (SYO), VITEK 2 system, and E-test for determining the MIC of clinical <em>C. albicans</em> isolates.</p></div><div><h3>Materials and methods</h3><p>The susceptibilities of 95 <em>C. albicans</em> isolates were compared between SYO, VITEK 2 system, and E-test with CLSI broth microdilution method. The categorical agreement (CA), essential agreement (EA), very major errors (VME), major errors (ME) and minor errors (MiE) were calculated.</p></div><div><h3>Results</h3><p>Our finding showed the CA varied for SYO from 96.8% to 100%, while the EA ranged from 91.6% to 100%. The SYO method showed 1.1% of VME and ME, and up to 3.2% of MiE. Next, the CA and EA ranges for the VITEK 2 system were 97.8%–100% and 23.2%–100%, respectively. In the VITEK 2 technique, 1.1% of VME were found. For the E-test, the CA varied from 83.2% to 100% while the EA ranged from 64.2% to 98.9%. The E-test method showed 1.1% of VME and up to 16.8% of MiE.</p></div><div><h3>Conclusions</h3><p>In conclusion, SYO and VITEK 2 (except flucytosine) could be potential alternatives to the CLSI broth microdilution method in determining the MIC of <em>C. albicans</em>.</p></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"50 ","pages":"Article 100663"},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141534289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fungal-associated pneumonia in patients with hematological malignancies 血液恶性肿瘤患者的真菌相关肺炎。
IF 1.4 4区 医学
Indian Journal of Medical Microbiology Pub Date : 2024-07-01 DOI: 10.1016/j.ijmmb.2024.100654
Sarai Pineda-Benítez, Beda D. Islas-Muñoz, Pamela Alatorre-Fernández, Cyntia Ibanes-Gutiérrez C, Patricia Volkow-Fernández, Patricia Cornejo-Juárez
{"title":"Fungal-associated pneumonia in patients with hematological malignancies","authors":"Sarai Pineda-Benítez,&nbsp;Beda D. Islas-Muñoz,&nbsp;Pamela Alatorre-Fernández,&nbsp;Cyntia Ibanes-Gutiérrez C,&nbsp;Patricia Volkow-Fernández,&nbsp;Patricia Cornejo-Juárez","doi":"10.1016/j.ijmmb.2024.100654","DOIUrl":"10.1016/j.ijmmb.2024.100654","url":null,"abstract":"<div><h3>Purpose</h3><p>Patients with hematologic malignancies (HM) are at high risk of invasive lung fungal infections (ILFI). To describe the main characteristics, treatment, and outcomes for five years in adult patients with HM and fungal pneumonia.</p></div><div><h3>Methods</h3><p>We conducted a retrospective study at Instituto Nacional de Cancerología (INCan), a referral tertiary care oncology hospital with 135 beds in Mexico City, Mexico. We included all cases of fungal pneumonia in patients with HM from January 1, 2017, to December 31, 2022. Cases were classified as proven, probable, and possible according to EORTC/MSG criteria 2021.</p></div><div><h3>Results</h3><p>Two hundred ten patients were included; the mean age was 40 years. The most frequent HM was acute lymphoblastic leukemia (n = 74) and acute myeloid leukemia (n = 68). One hundred forty patients (66.7%) had severe neutropenia for a median of 16 days. All patients had a CT thorax scan; in 132 (62.9%), multiple nodules were documented. Serum galactomannan (GM) was positive in 21/192 (10.9%) and bronchoalveolar lavage in 9/36 (25%). Fifty-three patients (25.2%) died in the first month. In the multivariate analysis for mortality in the first 30 days, hypoalbuminemia, shock, possible ILFI, and inappropriate antifungal treatment were statistically associated.</p></div><div><h3>Conclusions</h3><p>In high-risk HM patients, CT thorax scan and GM help diagnose ILFI. An appropriate antifungal improves mortality.</p></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"50 ","pages":"Article 100654"},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141456452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genomic surveillance of SARS-CoV-2 and emergence of XBB.1.16 variant in Rajasthan 拉贾斯坦邦的 SARS-CoV-2 基因组监测和 XBB.1.16 变异体的出现。
IF 1.4 4区 医学
Indian Journal of Medical Microbiology Pub Date : 2024-07-01 DOI: 10.1016/j.ijmmb.2024.100659
Pratibha Sharma , Swati Gautam , Abhaya Sharma , Dinesh Parsoya , Farah Deeba , Nita Pal , Ruchi Singh , Himanshu Sharma , Neha Bhomia , Ravi P. Sharma , Varsha Potdar , Bharti Malhotra
{"title":"Genomic surveillance of SARS-CoV-2 and emergence of XBB.1.16 variant in Rajasthan","authors":"Pratibha Sharma ,&nbsp;Swati Gautam ,&nbsp;Abhaya Sharma ,&nbsp;Dinesh Parsoya ,&nbsp;Farah Deeba ,&nbsp;Nita Pal ,&nbsp;Ruchi Singh ,&nbsp;Himanshu Sharma ,&nbsp;Neha Bhomia ,&nbsp;Ravi P. Sharma ,&nbsp;Varsha Potdar ,&nbsp;Bharti Malhotra","doi":"10.1016/j.ijmmb.2024.100659","DOIUrl":"10.1016/j.ijmmb.2024.100659","url":null,"abstract":"<div><h3>Purpose</h3><p>Genomic surveillance of positive SARS-CoV-2 samples is important to monitor the genetic changes occurring in virus, this was enhanced after the WHO designation of XBB.1.16 as a variant under monitoring in March 2023. From 5th February till May 6, 2023 all positive SARS-CoV-2 samples were monitored for genetic changes.</p></div><div><h3>Methods</h3><p>A total of 1757 samples having Ct value &lt;25 (for E and ORF gene) from different districts of Rajasthan were processed for Next Generation Sequencing (NGS). The FASTA files obtained on sequencing were used for lineage determination using Nextclade and phylogenetic tree construction.</p></div><div><h3>Results and conclusions</h3><p>Sequencing and lineage identification was done in 1624 samples. XBB.1.16 was the predominant lineage in 1413 (87.0%) cases while rest was other XBB (207, 12.74%) and other lineages (4, 0.2%). Of the 1413 XBB.1.16 cases, 57.47% were males and 42.53% were females. Majority (66.53%) belonged to 19–59 year age. 84.15% of XBB.1.16 cases were infected for the first time. Hospitalization was required in only 2.2% cases and death was reported in 5 (0.35%) patients. Most of the cases were symptomatic and the commonest symptoms were fever, cough and rhinorrhea. Co-morbidities were present in 414 (29.3%) cases. Enhanced genomic surveillance helped to rapidly identify the spread of XBB variant in Rajasthan. This in turn helped to take control measures to prevent spread of virus and estimate public health risks of the new variant relative to the previously circulating lineages. XBB variant was found to spread rapidly but produced milder disease.</p></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"50 ","pages":"Article 100659"},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141467625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A rare case report of meningoencephalitis caused by Streptococcus porcinus 猪链球菌引发脑膜脑炎的罕见病例报告。
IF 1.4 4区 医学
Indian Journal of Medical Microbiology Pub Date : 2024-07-01 DOI: 10.1016/j.ijmmb.2024.100660
Mridula Madiyal, Pratibha Bhat U, C.R. Sachin
{"title":"A rare case report of meningoencephalitis caused by Streptococcus porcinus","authors":"Mridula Madiyal,&nbsp;Pratibha Bhat U,&nbsp;C.R. Sachin","doi":"10.1016/j.ijmmb.2024.100660","DOIUrl":"10.1016/j.ijmmb.2024.100660","url":null,"abstract":"<div><p>Acute pyogenic meningitis is a medical emergency. Bacteria are the major causative agents of pyogenic meningitis with <em>Streptococcus pneumoniae, Haemophilus influenzae,</em> and <em>Neisseria meningitidis</em> being the most common. Here, we describe a case of bacterial meningoencephalitis caused by <em>Streptococcus porcinus</em>. To our knowledge this is the first case described in literature. The patient was treated with ceftriaxone and supportive treatment.</p></div>","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"50 ","pages":"Article 100660"},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141467624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aims and Scope 目标和范围
IF 1.4 4区 医学
Indian Journal of Medical Microbiology Pub Date : 2024-07-01 DOI: 10.1016/S0255-0857(24)00149-X
{"title":"Aims and Scope","authors":"","doi":"10.1016/S0255-0857(24)00149-X","DOIUrl":"10.1016/S0255-0857(24)00149-X","url":null,"abstract":"","PeriodicalId":13284,"journal":{"name":"Indian Journal of Medical Microbiology","volume":"50 ","pages":"Article 100674"},"PeriodicalIF":1.4,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S025508572400149X/pdfft?md5=7a286fadeb3c14ae0a2e2e68baa3a9ac&pid=1-s2.0-S025508572400149X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141952594","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信